期刊文献+

乳腺癌患者外周血ALDH1^(high)CD44^+CD24^(-/low)细胞含量变化及其临床意义 被引量:2

Change and clinical significance of ALDH1^(high)CD44^+CD24^(-/low) cells content in peripheral blood of patients with breast cancer
原文传递
导出
摘要 目的:检测乳腺癌患者外周血ALDH1highCD44+CD24-/low细胞含量的变化,探讨其与乳腺癌发生的关系及临床意义。方法:观察对象为46例Ⅰ期、Ⅱ期、Ⅲ期和Ⅳ期乳腺癌患者和12名健康女性志愿者(对照组)。采用流式细胞仪检测、分析各组外周血中ALDH1high细胞和ALDH1highCD44+CD24-/low细胞含量及其变化情况。结果:①所有样本均能检出ALDH1high细胞,各组间均数比较差异无统计学意义(P>0.05);②Ⅳ期乳腺癌组的外周血ALDH1highCD44+CD24-/low细胞含量与其他各组比较差异均有统计学意义(P<0.05),而其他各组间比较差异无统计学意义(P>0.05);③Ⅳ期乳腺癌患者原发癌灶免疫组化结果各不相同,但均可在外周血中检出ALDH1highCD44+CD24-/low细胞。结论:①各组中的ALDH1high细胞含量无显著差异,说明ALDH1具有普遍干细胞性质;②ALDH1highCD44+CD24-/low细胞含量与乳腺癌的发生有明显相关性。③ALDH1highCD44+CD24-/low细胞与乳腺癌的免疫分型无相关性。 Objective: To detect the change of ALDH1 h^sh CD44 + CD24 -/lo~ cells content in peripheral blood of patients with breast cancer, explore its relationship with the occurrence of breast cancer and its clinical significance. Methods: Forty -six patients with breast cancer of stage I , Ⅱ , Ⅲ, and IV, and twelve healthy women ( control group) were selected as observation groups ; flow cytometry was used to detect and analyze the content of ALDH1high CD44 + CD24-/low cells in peripheral blood and the change. Results: ALDH1hlgh cells could be detected in all the samples, there was no statistically significant difference in the mean among different groups ( P 〉 0. 05 ) . There was statistically significant difference in the content of ALDH1 high CD44 + CD24-/Jow cells in peripheral blood between breast cancer group of stage IV and the other groups ( P 〈 0. 05 ), but there was no statistically significant difference among the other groups ( P 〉 0.05 ) . Among the patients with breast cancer of stage IV, the immunohistochemical results of primary cancer varied, but ALDHlhlghCD44 + CD24 -/low cells could be detected in every sample. Conclusion: The content of ALDH1 high cells in different groups had no statistically significant difference, which indicates that ALDH1 is a universal stern cell marker. The content of ALDHlhishcIM4 + CD24-/low cells is significantly correlated with the occurrence of breast cancer. There is no correlation between ALDH1 hlghcD44 + CD24-/low cells and immunophenotype of breast cancer.
出处 《中国妇幼保健》 CAS 北大核心 2012年第26期4121-4123,共3页 Maternal and Child Health Care of China
关键词 乳腺癌 ALDH1highCD44+CD24-/low细胞 干细胞 流式细胞仪 Breast cancer ALDHlhighCD44 + CD24-/low cell Stem cell Flow cytometry
  • 相关文献

参考文献6

  • 1Al -hajj M, Wicha MS, Benito -Hernandez A et al. Prospec- tive identification of tumorigenic breast cancer cells [ J]. Proc Natl Acad Sci USA, 2003, 100 (7) : 3983.
  • 2Ginestier C, Hurm H, Charafe - Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [ J] . Cell Stem Cell, 2007, 1 (5): 555.
  • 3Croker A, Goodale D, Chu J et al. High aldehyde dehydrogen- ase and expression of cancer stem cell markers selects for breast cancer cancer cells with cells with enhanced malignant and metastatic ability [ J]. J Cell Mol Med, 2009, 13 (SB) : 2236.
  • 4Panayiotis A, Theodoropoulos, Hara Polioudaki et al. Circula- ting tumor cells with a putative stem cell phenotype in peripher- al blood of patients with breast cancer [ J]. Cancer Letter, 2009, 6 (27) : 485.
  • 5Bahriye Aktas, Mitra Tewes, Tanja Fehm et al. Stem cell and epithelial mesenchymal transition markers are frequently over- expressed in circulating tumor cells of metastatic breast cancer patients (J]. Clinical Cancer Res, 2009, 11 (46) : 920.
  • 6Reuben JM, Lee BN, Gao H et al. Primary breast cancer pa- tients with high percentages of bone marrow epithelial ceils with ALDH activity and CD44 + CD24-/low cancer stem cell pheno- type [J]. Eur J Cancer, 2011, 2 (18) : 1315.

同被引文献17

  • 1Bouras T,Pal B,Vaillant F,etal.Notch signaling regulatesmammary stem cell function and luminal cell-fate commitment[J].Cell stem cell,2008,3(4):429.
  • 2Thomas Schlange,Yutaka Matsuda,etal.Autocrine WNT sig-naling contributes to breast cancer cell proliferation via the canoni-cal WNT pathway and EGFR transactivation[J].Breast Cancer Re-search,2007,9(5):R63.
  • 3Emmanuelle Charafe-Jauffret,Christophe Ginestier,FloraIovino,etal.Breast cancer cell lines contain functional cancer stemcells with metastatic capacity and a distinct molecular signature[J].Cancer Res,2009,69(4):1302.
  • 4Tanei T,Morimoto K,Shimazu K,etal.Association of breastcancer stem cells identified by aldehyde dehydrogenase 1-expres-sion with resistance to sequential Paclitaxel and epirubicin basedchemotherapy for breast cancers[J].Clin cancer Res,2009,5(12):4234.
  • 5Heerma van Voss MR,van der Groep P,Bart J,etal.Expression of the stem cell marker ALDH1 in BRCA1 relatedbreast cancer[J].Cellular Onc,2011,34(1):3.
  • 6Yoshioka T,Umekita Y,Ohi Y,etal.Aldehyde dehydrogen-ase 1 expression is a predictor of poor prognosis in node-positivebreast cancers:a long-term follow-up study[J].Histopathology,2011,58(4):608.
  • 7AlyshaK.Croker,Alison L.Allan.Inhibition of aldehyde de-hydrogenase(ALDH)activity reduces chemotherapy and radiationresistance of stem-like ALDHhiCD44+human breast cancer cells[J].Breast Cancer Research and Treatment,2012,133(1):75.
  • 8Bruni CA,Lynch CC,Rosa RR,et al.MMP-2contributesto the development of the mouse ventral prostate by impacting epi-thelial growth and morphogenesis[J].Dev Dyn,2010,239:2386.
  • 9Rizzo P,Miao H,D'Souza G,et al.Cross-talk betweennotch and the estrogen receptor in breast cancer suggests noveltherapeutic approaches[J].Cancer Res.2008,68(13):5226.
  • 10Zang S,Chen F,Dai J,et al.RNAi-mediated knockdownof Notch-1 leads to cell growth inhibition and enhanced chemo-sensitivity in human breast cancer[J].Oncol Rep,2010,23(4):893.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部